CLINICAL TRIALS PROFILE FOR LANOXICAPS
✉ Email this page to a colleague
All Clinical Trials for LANOXICAPS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04887194 ↗ | PK Study to Assess Drug-drug Interaction Between Sitravatinib and a Cocktail of Substrates | Recruiting | Mirati Therapeutics Inc. | Phase 1 | 2021-03-26 | Study 516-010 is an open-label Phase 1, drug-drug interaction study evaluating the effect of sitravatinib on probe substrates for CYP450 enzymes and BCRP and P-gp transporters. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LANOXICAPS
Condition Name
Clinical Trial Locations for LANOXICAPS
Trials by Country
Clinical Trial Progress for LANOXICAPS
Clinical Trial Phase
Clinical Trial Sponsors for LANOXICAPS
Sponsor Name